RadNet Analyst Ratings
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating, Announces Target Price $94
Truist Financial Sticks to Their Buy Rating for Radnet (RDNT)
Truist Raises Price Target on RadNet to $94 From $80, Keeps Buy Rating
Truist Financial Initiates RadNet(RDNT.US) With Buy Rating
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating
Barclays Maintains RadNet(RDNT.US) With Buy Rating, Maintains Target Price $79
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Radnet (RDNT) and Eli Lilly & Co (LLY)
Radnet's Strategic Positioning in Digital Health and AI Market Drives Buy Rating
Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating, Announces Target Price $80
Truist Financial Sticks to Their Buy Rating for Radnet (RDNT)
RadNet Is Maintained at Buy by Jefferies
RadNet Analyst Ratings
Jefferies Maintains RadNet(RDNT.US) With Buy Rating, Raises Target Price to $80
Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC) and Radnet (RDNT)
Barclays Maintains RadNet(RDNT.US) With Buy Rating, Maintains Target Price $79
RadNet Raised to Overweight From Equal-Weight by Barclays
RadNet Analyst Ratings
Barclays Upgrades RadNet(RDNT.US) to Buy Rating, Raises Target Price to $79